On the molecular-weight-dependence of the anticoagulant activity of heparin
- PMID: 486155
- PMCID: PMC1161146
- DOI: 10.1042/bj1810241
On the molecular-weight-dependence of the anticoagulant activity of heparin
Abstract
The inactivation of thrombin and factor Xa by antithrombin was determined in the presence of heparin fractions of different molecular weights and with high affinity for antithrombin. The ability to potentiate the inactivation of either coagulation factor increased with increasing length of the polysaccharide chain.
Similar articles
-
Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.Can J Biochem Cell Biol. 1984 Oct;62(10):975-83. doi: 10.1139/o84-125. Can J Biochem Cell Biol. 1984. PMID: 6509363
-
Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.Biochim Biophys Acta. 1979 Sep 3;586(3):584-93. doi: 10.1016/0304-4165(79)90049-7. Biochim Biophys Acta. 1979. PMID: 476156
-
The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.Biochem J. 1981 Feb 1;193(2):395-400. doi: 10.1042/bj1930395. Biochem J. 1981. PMID: 6914196 Free PMC article.
-
Molecular weight of heparin versus biologic activity. Some additional considerations.Semin Thromb Hemost. 1985 Jan;11(1):29-33. doi: 10.1055/s-2007-1004355. Semin Thromb Hemost. 1985. PMID: 2579437 Review. No abstract available.
-
Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.Semin Thromb Hemost. 1985 Apr;11(2):133-7. doi: 10.1055/s-2007-1004370. Semin Thromb Hemost. 1985. PMID: 3898370 Review. No abstract available.
Cited by
-
Mechanism of the anticoagulant action of heparin.Mol Cell Biochem. 1982 Oct 29;48(3):161-82. doi: 10.1007/BF00421226. Mol Cell Biochem. 1982. PMID: 6757715 Review. No abstract available.
-
Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.Drugs Aging. 1997 Apr;10(4):299-322. doi: 10.2165/00002512-199710040-00006. Drugs Aging. 1997. PMID: 9108990 Review.
-
Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin III.J Clin Invest. 1985 Apr;75(4):1169-73. doi: 10.1172/JCI111812. J Clin Invest. 1985. PMID: 3988937 Free PMC article.
-
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.Biochem J. 1984 Mar 15;218(3):725-32. doi: 10.1042/bj2180725. Biochem J. 1984. PMID: 6721831 Free PMC article.
-
The relative molecular mass dependence of the anti-factor Xa properties of heparin.Biochem J. 1986 Sep 1;238(2):329-33. doi: 10.1042/bj2380329. Biochem J. 1986. PMID: 3800942 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources